Clinical trial
Metformin for the Treatment of Endometrial Hyperplasia
NCT01685762 is registered in ClinicalTrials.gov with UNC Lineberger Comprehensive Cancer Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Metformin for the Treatment of Endometrial Hyperplasia
- Lead sponsor
- UNC Lineberger Comprehensive Cancer Center
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- January 10, 2013
- Completion date
- December 1, 2015
- Enrollment
- 18 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
endometrial hyperplasia, endometrial hyperplasia without atypia